Kathryn Tucker, M.S. Senior Biostatistician, Director of Quality Assurance

View Biography Print this Section

Withers M, McKinney D, Ogutu B, Waitumbi J, Milman J, Apollo O, Allen O, Tucker K, Soisson L, Diggs C, Leach A, Wittes J, Dubovsky F, Stewart A, Remich S, Cohen J, Ballou R, Holland C, Lyon J, Angov E, Stoute J, Martin S, Heppner D. Safety and reactogenicity of an MSP-1 malaria vaccine candidate: a randomized, phase Ib, dose-escalation trial in Kenyan children. PLoS to appear, 2006.

Stoute JA, Gombe J, Withers MR, Siangla J, McKinney D, Onyango M, Cummings JF, Milman J, Tucker K, Soisson L, Stewart VA, Lyon JA, Angov E, Leach A, Cohen J, Kester KE, Ockenhouse CF, Holland CA, Diggs C, Wittes J, Heppner DG. Phase I randomized double-blind safety and immunogenicity trial of Plasmodium falciparum malaria merozoite surface protein FMP1 vaccine, adjuvanted with AS02A, in adults in western Kenya. Vaccine 2005; in press.

Stoute J, Withers M, Gombe J, Wasunna K, Cummings J, Ohas E, Kester K, McKinney D, Onyango M, Milman J, Ockenhouse C, Tucker K, Angov E, Diggs C, Leach A, Holland C, Cohen J, Tornieporth N, Lyon J, Heppner D. Double-blinded randomized safety and immunogenicity trial of P. falciparum MSP–1₄₂ adjuvanted in AS02A vs. Rabies vaccine in malaria-experienced adults in western Kenya. 3^rd MIM Pan-African Conference on Malaria, 2002.

Stoute J, Withers M, Gombe J, Wasunna K, Cummings J, Ohas E, Kester K, McKinney D, Onyango M, Milman J, Ockenhouse C, Tucker K, Angov E, Diggs C, Leach A, Holland C, Cohen J, Tornieporth N, Lyon J, Heppner D. Double-blinded randomized safety and immunogenicity trial of P. falciparum MSP–1₄₂ adjuvanted in AS02A vs. Rabies vaccine in malaria-experienced adults in western Kenya. Program of the 51^st Annual Meeting of the American Society of Tropical Medicine and Hygiene [Abstract #331]–Supplement to the American Journal of Tropical Medicine and Hygiene, 2002.

Diemert D, Dicko A, Malkin E, Thera M, Sagara I, Niambele M, Sogoba M, Assadou M, Ba M, Tucker K, Miller L, Klion K, Doumbo O. Longitudinal measurement of parasitemia as a predictor of clinical malarias in Mali. Program of the 52^nd Annual Meeting of the American Society of Tropical Medicine and Hygiene [Abstract #15]— Supplement to the American Journal of Tropical Medicine and Hygiene, 2003.

Withers M, McKinney D, Ogutu B, Waitumbi J, Milman J, Apollo O, Otieno A, Leach A, Tucker K, Holland C, Stewart V, Soisson L, Lyon J, Heppner D. A double-blind, randomized, controlled, dose escalation phase I field trial in 12 to 47 month old children in western Kenya to evaluate the safety and immunogenicity of FMP1/AS02A malaria vaccine vs. rabies vaccine. Program of the 53^rd Annual Meeting of the American Society of Tropical Medicine and Hygiene [Abstract #920]—Supplement to the American Journal of Tropical Medicine and Hygiene, 2004.

Ogutu B, Withers M, Onyango M, Otieno A, Waitumbi J, Heppner D, Tucker K, Milman J, Diggs C, Stoute J. A longitudinal cohort study of the epidemiology of pediatric malaria in Kombewa division, western Kenya. Program of the 53^rd Annual Meeting of the American Society of Tropical Medicine and Hygiene [Abstract #28]—Supplement to the American Journal of Tropical Medicine and Hygiene, 2004.

Thera M, …Diggs C, …Tucker K. Double blind randomized controlled phase I trial to evaluate the safety and immunogenicity of WRAIR’s MSP-1 candidate malaria antigen (FMP1) adjuvanted in GlaxoSmithKline Biologicals’ ASO2a vs. Rabies vaccine in semi-immune adults in Bandiagara, Mali. Program of the 53^rd Annual Meeting of the American Society of Tropical Medicine and Hygiene [Abstract #921]—Supplement to the American Journal of Tropical Medicine and Hygiene, 2004.